Cellceutix

Cellceutix is a biopharmaceutical company developing small molecule therapies in areas of unmet medical needs.

Cellceutix Corporation is an emerging bio-pharmaceutical company in the business of developing small molecule therapies in areas of unmet medical need. Our primary efforts are in cancer and inflammatory disease. We intend to spend most of our time initially on our lead product, Kevetrin, which is being developed for drug-resistant cancers. We've recently announced some exciting results in animal models of multi-drug resistant lung cancer.